LUNGPACER MEDICAL
Lungpacer Medical is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle The objective of the company is to develop and commercialize a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU). It is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach th... at is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. In addition, the paced diaphragm is expected to restore negative pressure ventilation, thereby potentially providing a more physiological respiratory pattern and reducing the levels of positive pressure ventilation and its harmful effects on the lungs. Lung Pacer was founded in 2009 and is headquartered in Vancouver, British Columbia, Canada.
LUNGPACER MEDICAL
Industry:
Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.lungpacer.com
Total Employee:
51+
Status:
Active
Contact:
(778)655-2100
Email Addresses:
[email protected]
Total Funding:
91.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache Wordpress Plugins Global Site Tag
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Lungpacer Medical
Keiretsu Capital
Keiretsu Capital investment in Angel Round - Lungpacer Medical
Keiretsu Forum
Keiretsu Forum investment in Angel Round - Lungpacer Medical
KCK Global
KCK Global investment in Angel Round - Lungpacer Medical
Official Site Inspections
http://www.lungpacer.com
- Host name: 26.67.167.72.host.secureserver.net
- IP address: 72.167.67.26
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Lungpacer Medical"
Company | Lungpacer Medical
The Lungpacer System is authorized for emergency use in healthcare settings to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure …See details»
Careers | Lungpacer Medical
Lungpacer is developing a novel therapeutic solution for preserving or restoring the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation.See details»
Lungpacer Medical - LinkedIn
Headquartered in Vancouver, Canada, and with US offices in Exton, Pennsylvania, Lungpacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients...See details»
Lungpacer Medical Company Profile - MedTech Innovator
FDA granted Lungpacer “breakthrough device” designation for its potential to save lives and improve outcome for MV patients who have difficulty weaning from MV. Lungpacer offers the …See details»
News | Lungpacer Medical
Nov 19, 2024 · Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off mechanical ventilation and breathe on their own. The RESCUE 3 study is the third in a …See details»
Lungpacer Medical - Board Governance - The Org
The Board Governance team at Lungpacer Medical is responsible for ensuring effective oversight and strategic direction for the company. Comprising experienced board members, this team …See details»
Lungpacer Medical Company Profile - Office Locations ... - Craft
Lungpacer Medical is a company developing a therapeutic solution for preserving or restoring the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical …See details»
MedStar Health Investigators study breakthrough …
Apr 18, 2022 · Discover breakthrough research at MHRI. Learn how our team is helping patients recover faster and get off the ventilator sooner by studying Lungpacer’s AeroPace System.See details»
Lungpacer Medical in its US$20 million Series B funding round
Vancouver, Canada-based Lungpacer Medical Inc. raised US$20 million of Series B venture funding from WJFS and its existing lead investor 4CGE. Lungpacer develops a diaphragm …See details»
Lungpacer | Lungpacer News and Press Releases
Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off mechanical ventilation and breathe on their own. The …See details»
New medical device aims to stimulate COVID patients’ …
Sep 13, 2020 · Lungpacer Medical recently wrapped up a randomized, controlled, multi-center trial of the device in Europe. In this trial, therapy using the device improved diaphragm strength by over 200% compared to traditional treatment.See details»
Temporary transvenous diaphragm pacing vs. standard of care for …
Jan 17, 2019 · This paper describes the protocol of a randomized, controlled, open-label, multicenter trial that is designed to investigate the safety and effectiveness of a novel therapy, …See details»
FACT SHEET FOR HEALTHCARE PROVIDERS - U.S. Food and Drug …
• The Lungpacer Diaphragm Pacing Therapy System is authorized for use in healthcare settings to assist in weaning patients on invasive mechanical ventilation who have been determined by …See details»
Lungpacer Medical Receives FDA Emergency Use Authorization for …
Apr 28, 2020 · Lungpacer DPTS is the first minimally invasive, temporary, transvenous phrenic-stimulation system cleared through Emergency Use Authorization by the FDA. This non …See details»
Research | Lungpacer Medical
Lungpacer Medical is currently enrolling patients in a pivotal clinical study, RESCUE 3. The study will help evaluate the safety and efficacy of the device to seek regulatory approval of the …See details»
Improvements in Multiple Respiratory Measures Reported in …
Sep 8, 2020 · The Lungpacer System is a novel, first-in-class, temporary transvenous diaphragm neurostimulation system, FDA-designated as a breakthrough device, with FDA Emergency …See details»
Lungpacer Medical Accelerates Pivotal Clinical Study with …
EXTON, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a …See details»
AeroPace | Lungpacer Medical
Lungpacer’s AeroPace™ system is designed as a personal trainer for the diaphragm muscle. AeroPace system is designed to stimulate the nerves that activate the diaphragm with …See details»
American Journal of Respiratory and Critical Care Medicine
Objectives: To evaluate the effects of temporary transvenous diaphragm neurostimulation on weaning outcome and maximal inspiratory pressure. Methods: Multicenter, open-label, …See details»